Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi

American Journal of Cardiology

Volumn 78, Issue 5, 1996, Pages 562-564

  Nallamouthu, Nasaraiah ^a   Araujo, Luis ^a   Russell, Joseph ^a   Heo, Jaekyeong ^a   Iskandrian, Ami E ^a,b  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AGED; ARTICLE; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HEART; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; SCINTISCANNING;

AGED; CORONARY DISEASE; EXERCISE TEST; FEMALE; HEART; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; STROKE VOLUME; TECHNETIUM TC 99M SESTAMIBI; VENTRICULAR FUNCTION, LEFT;

EID: 0030236124     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00366-9     Document Type: Article

References (26)

1. Iskandrian AE, Hakki AH, Schwarte JS, Kay H, Mattleman S, Kane S. Prognostic implications of rest and exercise radionuclide ventriculography in patients with suspected or proven coronary heart disease. Int J Cardiol 1984;6:707-718.
2. Iskandrian AE, Hakki AH, Kane-Marsh S. Prognostic implications of exercise thallium-201 scintigraphy in patients with suspected or known coronary artery disease. Am Heart J 1985;110:135-143.
3. Hung J, Goris ML, Nash E, Kraemer HC, Debusk RF, Berger WE III, Lew H. Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and radionuclide ventriculography for distinguishing high- and low-risk patients soon after myocardial infarction. Am J Cardiol 1984;53:1221-1227.
4. Pryor DB, Harrell FE, Lee KL, Rosati RA, Coleman RE, Cobb FR, Califf RM, Jones RH. Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol 1984;53:18-22.
5. Lee KL, Pryor DB, Pieper KS, Harrell FE Jr, Califf RM, Mark DB, Hiatky MA, Coleman RE, Cobb FR, Jones RH. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease: a comparison with clinical and catheterization variables. Circulation 1990;82:1705-1717.
6. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age. Circulation 1991;83:363-381.
7. Pollock SG, Abbott RD, Boucher CA, Beller GA, Kaul S. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Circulation 1992;85:237-248.
8. Iskandrian AE, Chae SC, Heo J, Stanberry CD, Wasserieben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-670.
9. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, Macintyre WJ, Thomas JD. Prognosis of patients with left ventricular dysfunction with and without viable myocardium after myocardial infarction. Relative efficacy of medial therapy and revascularization. Circulation 1994;90:2687-2694.
10. Machecourt J, Longere P, Fagret D, Vanzetto G, Wolf JE, Polldori C, Comet M, Denis B. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect: study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 1994;23:1096-1106.
11. Port SC. The role of radionuclide ventriculography in the assessment of prognosis in patients with coronary artery disease. J Nucl Med 1994;35:721-725.
12. Cox JL, Wright LM, Burns RJ. Prognostic significance of increased thallium-201 lung uptake during dipyridamole myocardial scintigraphy. Comparison with exercise scintigraphy. Can J Cardiol 1995;11:689-694.
13. Jones RH, Borges-Neto S, Potts JM. Simultaneous measurement of myocardial perfusion and ventricular function during exercise from a single injection of technetium-99m sestamibi in coronary artery disease. Am J Cardiol 1990;66:68E-71E.
14. Borges-Neto S, Puma J, Jones RH, Sketch MH Jr, Stack R, Hanson MW, Coleman RE. Myocardial perfusion and ventricular function measurements during total coronary occlusion in humans. A comparison with rest and exercise radionuclide studies. Circulation 1994;89:278-284.
15. Gallik DM, Obermueller SD, Swarna US, Guildry GW, Mahmarian JJ, Verani MS. Simultaneous assessment of myocardial perfusion and left ventricular function during transient coronary occlusion. J Am Coll Cardiol 1995;25:1529-1538.
16. Chua T, Kiat H, Germano G, Maurer G, Van Train K, Feldman J, Berman D. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, post-exercise regional ventricular function and myocardial viability: correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1107-1114.
17. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-2147.
18. Heo J, Kegel J, Iskandrian AE. Comparison of same-day protocols using technetium-99m sestamibi myocardial imaging. J Nucl Med 1992;33:186-191.
19. Iskandrian AE, Kegel JG, Tecce MA, Wasserieben V, Cave V, Heo J. Simultaneous assessment of left ventricular perfusion and function with technetium-99m sestamibi after coronary artery bypass grafting. Am Heart J 1993;126:1199-1204.
20. Fattah AA, Kamal A, Pancholy S, Heo J, Iskandrian AE. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. Am J Cardiol 1994;74:769-771.
21. Nallamouthu N, Pancholy S, Lee KR, Heo J, Iskandrian AE. Impact of exercise single-photon emission computed tomographic thallium imaging on patient management and outcome. J Nucl Cardiol 1995;4:334-338.
22. Pryor DB, Harrell FR Jr, Lee KL, Califf RM, Rosati RA. Estimating the likelihood of significant coronary artery disease. Am J Med 1983;75:771-780.
23. Marie PY, Danchin N, Durand JF, Feldmann L, Grentzinger A, Oliver P, Karcher G, Juilliere Y, Virion JM, Beurrier D, Cherrier F, Bertrand A. Longterm prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data. J Am Coll Cardiol 1995;26:879-886.
24. Palmas W, Friedman JD, Diamond GA, Silber H, Kiat H, Berman DS. Incremental value of simultaneous assessment of myocardial function and perfusion with technetium-99m sestamibi for prediction of extent of coronary artery disease. J Am Coll Cardiol 1995;25:1024-1031.
25. The multicenter postinfarction research group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;310:331-336.
26. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984;311:133-139.